Wave Life Sciences

$9.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.45 (+4.78%) As of 4:44 PM UTC today

Why Robinhood?

You can buy or sell WVE and other stocks, options, and ETFs commission-free!

About WVE

Wave Life Sciences Ltd. Ordinary Shares, also called Wave Life Sciences, is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore. The listed name for WVE is Wave Life Sciences Ltd. Ordinary Shares.

CEO
Paul B. Bolno
Employees
301
Headquarters
Singapore, Central Singapore
Founded
2012
Market Cap
504.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
455.63K
High Today
$10.03
Low Today
$9.25
Open Price
$9.49
Volume
158.66K
52 Week High
$19.98
52 Week Low
$6.61

WVE Earnings

-$1.65
-$1.10
-$0.55
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 4, Pre-Market

You May Also Like

EDI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure